logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/06/2025
Barclays: Maintain rating for Kinder Morgan (KMI.US) from Hold to Buy, with target price adjusted from $31.00 to $32.00.
Latest
2 m ago
Novo Nordisk: A decision on the application for label expansion of Ozempic in the United States is expected to be made in the fourth quarter of 2025.
2 m ago
Oman Air temporarily suspended flights to and from Medina, Dubai, and Kuwait during the regional situation development.
3 m ago
The stock price of Anjin has plummeted by 6% rapidly.
3 m ago
Anjin's stock price plummeted 6% rapidly.
3 m ago
Market news: Anjin's weight loss drug Maritide showed an average weight loss of 20% in the first part of the second phase of clinical trials.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.